HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

ibritumomab tiuxetan (Zevalin)

90Y-labeled anti-CD20 monoclonal antibody for radioimmunotherapy for patients with relapsed B-cell non-Hodgkin's lymphoma
Also Known As:
Zevalin; IDEC brand of ibritumomab tiuxetan; IDEC-Y2B8; yttrium-90-ibritumomab tiuxetan
Networked: 236 relevant articles (32 outcomes, 63 trials/studies)

Relationship Network

Drug Context: Research Results

Experts

1. Witzig, Thomas E: 19 articles (07/2013 - 02/2002)
2. Gordon, Leo I: 19 articles (10/2009 - 02/2002)
3. Emmanouilides, Christos: 15 articles (01/2009 - 02/2002)
4. Wiseman, Gregory A: 13 articles (07/2013 - 02/2002)
5. White, Christine A: 12 articles (04/2009 - 02/2002)
6. Molina, Arturo: 12 articles (04/2009 - 06/2004)
7. Schilder, Russell J: 9 articles (09/2007 - 06/2002)
8. Morschhauser, Franck: 7 articles (12/2014 - 07/2007)
9. Grillo-López, Antonio J: 7 articles (02/2005 - 02/2002)
10. Zinzani, Pier Luigi: 6 articles (03/2014 - 07/2007)

Related Diseases

1. Non-Hodgkin Lymphoma (Lymphosarcoma)
2. Lymphoma (Lymphomas)
3. Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
4. B-Cell Lymphoma (Lymphoma, B Cell)
5. Thrombocytopenia (Thrombopenia)

Related Drugs and Biologics

1. ibritumomab tiuxetan (Zevalin)
2. rituximab (Mabthera)
3. Yttrium
4. Etoposide (VP 16)
5. Melphalan (Alkeran)
6. fludarabine
7. Cytarabine (Cytosar-U)
8. Carmustine (FIVB)
9. Cyclophosphamide (Cytoxan)
10. Mitoxantrone (Novantrone)

Related Therapies and Procedures

1. Radioimmunotherapy
2. Drug Therapy (Chemotherapy)
3. Stem Cell Transplantation
4. Radiotherapy
5. Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation)